Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02263339 · ClinicalTrials.gov registry record · NA

Exercise & Brain Health in MS

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02263339: Completed NA study, sponsored by Oregon Health and Science University.

NCT02263339 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02263339, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about multiple sclerosis (MS). The investigators are studying whether aerobic exercise is better than a stretching program at improving brain health in people with MS. We want to learn: 1. If it is safe and practical for people with MS to participate in an aerobic exercise program with the goal of increasing cardiac fitness. Cardiac fitness is measured with exercise stress tests at the beginning and end of the study. 2. If aerobic exercise improves brain metabolism, a reflection of brain health, more than stretching. Brain metabolism is measured by MRIs at the beginning and end of the study. There is a 50% chance of being in the aerobic exercise or the stretching program. There are between 8 and 36 visits to OHSU, depending on the intervention group. The total duration of the study is at most 21 weeks.

Primary Outcome

1. Changes in VO2Max testing consists of an aerobic exercise test on a treadmill or stationary bicycle to measure blood pressure, heart rate, and oxygen consumption, and lung function tests 2. Brain ATP production is measured using a 31P MRSI imaging procedure: MRI data is collected using 7 tesla MRI instrument. All MRI data will be collected within 1.25 hour on each session (2.5 hour total/subject).

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Stretching
  • BEHAVIORAL Aerobic Exercise- Healthy Subjects

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2014-09
Est. Completion 2016-05-25
Phase NA

What the finished NCT02263339 record still lists

NCT02263339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Aerobic Exercise is the first listed.

NCT02263339 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02263339 about?

NCT02263339 is a clinical study titled "Exercise & Brain Health in MS". The purpose of this study is to learn more about multiple sclerosis (MS). The investigators are studying whether aerobic exercise is better than a stretching program at improving brain health in people with MS. We want to learn: 1. If it is safe and practical for people with MS to participate in an...

What is the current status of trial NCT02263339?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-09. Estimated completion is 2016-05-25.

What interventions are being tested in trial NCT02263339?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Stretching (BEHAVIORAL), Aerobic Exercise- Healthy Subjects (BEHAVIORAL).

Who is sponsoring clinical trial NCT02263339?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02263339's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02263339, the US trial registry maintained by the National Library of Medicine. NCT02263339 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.